Alpha-defensins and clostridium difficile recent growing concerns in inflammatory bowel disease.
Savoye
Guillaume
G
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001426:Bacterial Proteins / Q000378:metabolism; D001427:Bacterial Toxins / Q000378:metabolism; D016360:Clostridioides difficile / Q000378:metabolism*; D004761:Enterocolitis, Pseudomembranous; D015212:Inflammatory Bowel Diseases / Q000378:metabolism*; D019804:Mesalamine / Q000627:therapeutic use; D023084:alpha-Defensins / Q000378:metabolism*
D000893:Anti-Inflammatory Agents; D001426:Bacterial Proteins; D001427:Bacterial Toxins; D023084:alpha-Defensins; C031815:toxB protein, Clostridium difficile; D019804:Mesalamine